BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 23382631)

  • 21. The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry.
    Sahin S; Ekinci O; Seckin S; Dursun A
    Ann Ital Chir; 2017; 88():311-317. PubMed ID: 28566557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Helpful parameter for malignant potential of gastrointestinal stromal tumors (GIST).
    Wang X; Mori I; Tang W; Utsunomiya H; Nakamura M; Nakamura Y; Zhou G; Kennichi K
    Jpn J Clin Oncol; 2002 Sep; 32(9):347-51. PubMed ID: 12417600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].
    Sun XF; Gao XD; Yuan W; Sun JY; Fu M; Xue AW; Li H; Shu P; Fang Y; Hou YY; Shen KT; Sun YH; Qin J; Qin XY
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Sep; 23(9):880-887. PubMed ID: 32927513
    [No Abstract]   [Full Text] [Related]  

  • 24. Low ING4 protein expression detected by paraffin-section immunohistochemistry is associated with poor prognosis in untreated patients with gastrointestinal stromal tumors.
    Nanding A; Tang L; Cai L; Chen H; Geng J; Liu X; Ning X; Li X; Zhang Q
    Gastric Cancer; 2014 Jan; 17(1):87-96. PubMed ID: 23504291
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic significance of clinicopathologic parameters in gastrointestinal stromal tumor: a study of 156 cases].
    Liang YM; Li XH; Lü YY; Lü YL; Zhong M; Pu XL; Li WM
    Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):233-8. PubMed ID: 17706113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma.
    Ladstein RG; Bachmann IM; Straume O; Akslen LA
    BMC Cancer; 2010 Apr; 10():140. PubMed ID: 20398247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of SOCS6: an unfavorable prognostic factor for gastrointestinal stromal tumor proven by survival analysis.
    Ouyang J; An T; Wang Y; Lu X; Zhang Y; Wang X; Zhang X; Zhang C
    Diagn Pathol; 2021 Dec; 16(1):113. PubMed ID: 34895274
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgical treatment and prognostic analysis for gastrointestinal stromal tumors (GISTs) of the small intestine: before the era of imatinib mesylate.
    Wu TJ; Lee LY; Yeh CN; Wu PY; Chao TC; Hwang TL; Jan YY; Chen MF
    BMC Gastroenterol; 2006 Oct; 6():29. PubMed ID: 17062131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).
    Dematteo RP; Gold JS; Saran L; Gönen M; Liau KH; Maki RG; Singer S; Besmer P; Brennan MF; Antonescu CR
    Cancer; 2008 Feb; 112(3):608-15. PubMed ID: 18076015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
    Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.
    Koay MH; Goh YW; Iacopetta B; Grieu F; Segal A; Sterrett GF; Platten M; Spagnolo DV
    Pathology; 2005 Feb; 37(1):22-31. PubMed ID: 15875730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic Gastrointestinal Stromal Tumor: Clinicopathologic Features and Prognosis.
    Liu Z; Tian Y; Xu G; Liu S; Guo M; Lian X; Fan D; Zhang H; Feng F
    J Clin Gastroenterol; 2017 Oct; 51(9):850-856. PubMed ID: 27673752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ki67 as a prognostic factor for long-term outcome following surgery in gastrointestinal stromal tumors.
    Turkel Kucukmetin N; Cicek B; Saruc M; Ersoy O; Vardareli E; Onder O; Gurluler E; Tiftikci A; Goksel S; Tozun N
    Eur J Gastroenterol Hepatol; 2015 Nov; 27(11):1276-80. PubMed ID: 26275084
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
    Wang Y; Chen JJ; Wang XF; Wang Q
    World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
    Miettinen M; Sobin LH; Lasota J
    Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinicopathological features and prognosis of gastrointestinal stromal tumors with
    Shen YY; Li XQ; Yang LX; Fang Y; Nie MM; He ZR; Hou YY; Cao H; Wang M; Shen KT
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Sep; 24(9):804-813. PubMed ID: 34530562
    [No Abstract]   [Full Text] [Related]  

  • 37. Gastrointestinal stromal tumor: 15-years' experience in a single center.
    Wang M; Xu J; Zhang Y; Tu L; Qiu WQ; Wang CJ; Shen YY; Liu Q; Cao H
    BMC Surg; 2014 Nov; 14():93. PubMed ID: 25403624
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Natural history of imatinib-naive GISTs: a retrospective analysis of 929 cases with long-term follow-up and development of a survival nomogram based on mitotic index and size as continuous variables.
    Rossi S; Miceli R; Messerini L; Bearzi I; Mazzoleni G; Capella C; Arrigoni G; Sonzogni A; Sidoni A; Toffolatti L; Laurino L; Mariani L; Vinaccia V; Gnocchi C; Gronchi A; Casali PG; Dei Tos AP
    Am J Surg Pathol; 2011 Nov; 35(11):1646-56. PubMed ID: 21997685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation of immunophenotype with progression-free survival in patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    Chirieac LR; Trent JC; Steinert DM; Choi H; Yang Y; Zhang J; Patel SR; Benjamin RS; Raymond AK
    Cancer; 2006 Nov; 107(9):2237-44. PubMed ID: 16998931
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new nomogram for recurrence-free survival prediction of gastrointestinal stromal tumors: Comparison with current risk classification methods.
    Chen T; Xu L; Ye L; Qiu H; Hu Y; Liu H; Zhou Z; Li G; Yu J
    Eur J Surg Oncol; 2019 Jun; 45(6):1109-1114. PubMed ID: 30594406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.